AGER and chronic obstructive pulmonary disease: Biomarkers of progressive COPD include a reduction in the circulating levels of Clara cell secretory protein-16 (CC-16), soluble receptor for advanced glycation end-product (sRAGE), and syndecans [88,89,90].